纳入PLGA纳米颗粒的反意义寡核酸的静脉注射改变了器官分布的模式和基因淘汰效应
Yuta Yagi1,2, Takanatsu Hosokawa1, Takuro Yamada1
1Graduate School of Systems Life Sciences, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.
Molecular pharmaceutics
|July 19, 2025
概括
纳米粒子有效地将反感性寡核酸 (ASO) 传递给多个器官,增强心脏,肺部和脏中的基因敲除 (KD). 这种新的输送系统扩大了ASO治疗的治疗点,超越了肝脏.
科学领域:
- 生物技术是生物技术.
- 药物输送系统 药物输送系统
- 分子生物学分子生物学
背景情况:
- 反感性寡核酸 (ASOs) 显示出治疗疾病的希望,但由于药理动力学,它们仅限于向肝脏.
- 开发有效的输送系统对于将ASO的治疗应用扩展到其他器官至关重要.
研究的目的:
- 分析纳米粒子 (NP) 中结合的ASO的生物分布和基因淘汰 (KD) 活动.
- 调查NP-ASO系统在向肝脏以外的器官方面的潜力.
主要方法:
- 将ASO纳入可生物降解的poly ((乳酸-co-糖酸) 纳米粒子 (NP).
- 在小鼠的各种器官中评估ASO生物分布和KD效应,使用Malat1基因作为目标.
- 将NP-ASO与赤裸ASO治疗在降低剂量的比较.
主要成果:
- 与裸体ASO相比,NP显著增加了ASO在肝脏,脏,肺和心脏中的积累.
- 即使在较低剂量中,NP-ASO也显示了基因KD对心脏,肺和的影响.
- 由于细胞敏感性差异,高器官积累并不总是与KD效应相关.
结论:
- 装载ASO的NP为增强生物分布和多个器官中的基因KD提供了一个有希望的策略.
- 这种传递系统可促进ASO向异常器官,从而有可能减少副作用并扩大治疗选择.
相关概念视频
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K


